| Medical Mutual | Darzalex Faspro® (daratumumab and hyaluronidase-fihj) (Subcutaneous) (EOV) | 2026-04-01 |
| Medical Mutual | Darzalex® (daratumumab) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Elfabrio® (pegunigalsidase alfa-iwxj) (Intravenous) | 2026-04-01 |
| Medical Mutual | Elrexfio® (elranatamab-bcmm) (Subcutaneous) (EOV) | 2026-04-01 |
| Medical Mutual | Elzonris® (tagraxofusp-erzs) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Empliciti® (elotuzumab) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Elelyso® (taliglucerase alfa) (Intravenous) | 2026-04-01 |
| Medical Mutual | Erbitux® (cetuximab) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Romidepsin: Istodax® (Intravenous) | 2026-04-01 |
| Medical Mutual | Kyprolis® (carfilzomib) (Intravenous) (EOV) | 2026-04-01 |